Adient is a provider of absorbable medical devices for the prevention of pulmonary embolism in patients.
Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 30, 2022 | Series Unknown | $14.31M | — | — | — | Detail |
Jan 30, 2018 | Series Unknown | — | 1 | — | — | Detail |
Jun 26, 2017 | Debt Financing | $1.20M | 1 | — | — | Detail |
Oct 19, 2016 | Grant | — | 1 | — | — | Detail |
Jul 13, 2016 | Series C | $1.46M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
JF2 Capital Partners | — | Series Unknown |
Broadview Ventures | — | Debt Financing |
MedTech Innovator | — | Grant |
Green Park & Golf Ventures | — | Series C |
Houston Angel Network | — | Series C |
Texas HALO Fund | — | Series C |
TMCx Accelerator | — | Seed |
Idris Ayodeji Bello | — | Angel |